Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Egalet Corp (EGLT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 24,242
  • Shares Outstanding, K 52,700
  • Annual Sales, $ 26,140 K
  • Annual Income, $ -69,360 K
  • 36-Month Beta 0.57
  • Price/Sales 0.92
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.03
  • Most Recent Earnings -1.04 on 08/09/17
  • Next Earnings Date 08/08/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.42 +9.52%
on 05/29/18
0.53 -13.21%
on 06/13/18
-0.05 (-10.51%)
since 05/18/18
3-Month
0.42 +9.52%
on 05/29/18
0.91 -49.51%
on 03/20/18
-0.46 (-50.00%)
since 03/19/18
52-Week
0.42 +9.52%
on 05/29/18
2.62 -82.44%
on 06/20/17
-2.41 (-83.97%)
since 06/19/17

Most Recent Stories

More News
Egalet Appoints Industry Veteran John Varian to Board of Directors

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions,...

EGLT : 0.46 (unch)
Egalet to Participate in Panels at 2018 BIO International Convention and JMP Life Sciences Conference

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions,...

EGLT : 0.46 (unch)
Egalet Announces Large Regional Plan to Cover SPRIX® Nasal Spray

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions,...

EGLT : 0.46 (unch)
Egalet Reports First Quarter 2018 Financial Results

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions,...

EGLT : 0.46 (unch)
Egalet Announces National Pharmacy Benefit Manager to Cover SPRIX® Nasal Spray and ARYMO® ER

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions,...

EGLT : 0.46 (unch)
Egalet to Present at the 3rd Annual Disruptive Growth & Healthcare Conference

WAYNE, PA / ACCESSWIRE / May 2, 2018 / Egalet Corporation (NASDAQ: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments...

EGLT : 0.46 (unch)
Egalet Presented Data at American Academy of Pain Medicine Examining the Potential of ARYMO® ER to Deter Opioid Abuse

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions,...

EGLT : 0.46 (unch)
Egalet to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results on May 8, 2018

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions,...

EGLT : 0.46 (unch)
Factors of Influence in 2018, Key Indicators and Opportunity within Clifton, CSG Systems International, ArcelorMittal, Denny's, Yamana Gold, and Egalet -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Clifton Bancorp Inc. (NASDAQ:CSBK),...

CSGS : 43.29 (-0.62%)
AUY : 3.04 (+1.67%)
CSBK : 15.65 (+0.45%)
MT : 31.62 (-3.71%)
EGLT : 0.46 (unch)
DENN : 16.12 (+1.83%)
Data Shows That the Global Addiction Treatment Market is Set to Grow

Data provided by Transparency Market Research, indicates that global addiction treatment market was valued at approximately US$ 4.0 billion in 2016 and is anticipated to expand at a CAGR of over 6.0% from...

BICX : 0.1350 (-2.53%)
DRRX : 2.10 (-3.23%)
TTNP : 1.00 (-0.99%)
BDSI : 2.78 (-0.89%)
EGLT : 0.46 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade EGLT with:

Business Summary

Egalet Corporation is a specialty pharmaceutical company. The Company is engaged in the developing and planning to commercialize proprietary, abuse-deterrent oral products for the treatment of pain and in other indications. Its principal product candidate consist of Egalet-001, is an abuse-deterrent,...

See More

Key Turning Points

2nd Resistance Point 0.49
1st Resistance Point 0.47
Last Price 0.46
1st Support Level 0.45
2nd Support Level 0.45

See More

52-Week High 2.62
Fibonacci 61.8% 1.78
Fibonacci 50% 1.52
Fibonacci 38.2% 1.26
Last Price 0.46
52-Week Low 0.42

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar